Patent · US Expired

N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N -methylglycinamides

US4672058A · kind A · utility

7Cited by
6References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 1985
Grant dateJun 9, 1987
Priority date—
Expiry dateJun 10, 2005

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C327/48
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein are tolrestat amides and methods of preparation. The amides are new aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.